TickerFactsScreenerDevelopers

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2010: $5.0K2011: $48.0K2012: $90.0K2013: $108.0K2014: $161.0K2015: $45.0K2016: $103.0K2017: $180.0K2018: $369.0K2019: $473.0K2020: $378.0K2021: $330.0K2022: $29.0K2023: $18.0K$18.0K
2010Capital Expenditures (USD)2023
Fiscal YearCapital ExpendituresChange YoY
2023$18.0K-37.9%
2022$29.0K-91.2%
2021$330.0K-12.7%
2020$378.0K-20.1%
2019$473.0K+28.2%
2018$369.0K+105.0%
2017$180.0K+74.8%
2016$103.0K+128.9%
2015$45.0K-72.0%
2014$161.0K+49.1%
2013$108.0K+20.0%
2012$90.0K+87.5%
2011$48.0K+860.0%
2010$5.0K—